Cengizhan Erdem

730 total citations
32 papers, 422 citations indexed

About

Cengizhan Erdem is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Cengizhan Erdem has authored 32 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 15 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Cengizhan Erdem's work include Nonmelanoma Skin Cancer Studies (10 papers), Nail Diseases and Treatments (6 papers) and Cutaneous Melanoma Detection and Management (6 papers). Cengizhan Erdem is often cited by papers focused on Nonmelanoma Skin Cancer Studies (10 papers), Nail Diseases and Treatments (6 papers) and Cutaneous Melanoma Detection and Management (6 papers). Cengizhan Erdem collaborates with scholars based in Türkiye, Australia and United States. Cengizhan Erdem's co-authors include Bengü Nisa Akay, Aylın Okçu Heper, Pelin Koçyiğit, Ranâ Anadolu, Nihal Kundakçı, Ahu Bırol, Ayşe Boyvat, Erbak Gürgey, Seher Bostancı and Cliff Rosendahl and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Scandinavian Journal of Gastroenterology.

In The Last Decade

Cengizhan Erdem

27 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cengizhan Erdem Türkiye 12 225 216 173 45 45 32 422
William M. Ramsdell United States 9 165 0.7× 141 0.7× 128 0.7× 69 1.5× 26 0.6× 12 388
Cristina Bordea United Kingdom 8 189 0.8× 346 1.6× 308 1.8× 64 1.4× 26 0.6× 11 502
Enrique Herrera‐Acosta Spain 12 158 0.7× 172 0.8× 100 0.6× 35 0.8× 63 1.4× 40 352
Rodrigo Roldán–Marín Mexico 11 158 0.7× 190 0.9× 203 1.2× 106 2.4× 33 0.7× 28 473
Fezal Özdemir Türkiye 12 236 1.0× 178 0.8× 239 1.4× 43 1.0× 75 1.7× 39 425
Edith Arzberger Austria 11 311 1.4× 199 0.9× 224 1.3× 24 0.5× 166 3.7× 34 466
Ivette Alarcón Spain 14 248 1.1× 228 1.1× 326 1.9× 59 1.3× 16 0.4× 37 547
Paul Zenahlik Austria 8 205 0.9× 128 0.6× 117 0.7× 43 1.0× 159 3.5× 10 506
Vicenç García-Patos Spain 13 154 0.7× 114 0.5× 113 0.7× 120 2.7× 38 0.8× 15 406
Daniel J. Tanner United States 6 189 0.8× 366 1.7× 154 0.9× 76 1.7× 52 1.2× 7 580

Countries citing papers authored by Cengizhan Erdem

Since Specialization
Citations

This map shows the geographic impact of Cengizhan Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cengizhan Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cengizhan Erdem more than expected).

Fields of papers citing papers by Cengizhan Erdem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cengizhan Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cengizhan Erdem. The network helps show where Cengizhan Erdem may publish in the future.

Co-authorship network of co-authors of Cengizhan Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of Cengizhan Erdem. A scholar is included among the top collaborators of Cengizhan Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cengizhan Erdem. Cengizhan Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdem, Cengizhan, et al.. (2025). The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer. Diagnostics. 15(14). 1740–1740.
3.
Vural, Seçil, Bengü Nisa Akay, Ayşe Boyvat, et al.. (2019). Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy. Dermatologic Therapy. 32(5). e13003–e13003. 21 indexed citations
4.
Kundakçı, Nihal & Cengizhan Erdem. (2019). Leprosy: A great imitator. Clinics in Dermatology. 37(3). 200–212. 28 indexed citations
5.
Akay, Bengü Nisa, et al.. (2015). Dermoscopic changes in melanocytic nevi in patients receiving immunosuppressive and biologic treatments: Results of a prospective case-control study. Journal of the American Academy of Dermatology. 73(4). 623–629. 15 indexed citations
6.
Akay, Bengü Nisa, et al.. (2015). Dermatoscopic findings of atrophic dermatofibroma protuberans. Dermatology Practical & Conceptual. 5(1). 71–73. 6 indexed citations
7.
Erdem, Cengizhan, et al.. (2013). Deri Eki Tümörleri. 6(3). 44–49. 1 indexed citations
8.
Akay, Bengü Nisa, Pelin Koçyiğit, Aylın Okçu Heper, & Cengizhan Erdem. (2010). Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna. British Journal of Dermatology. 163(6). 1212–1217. 82 indexed citations
9.
Atasoy, Mustafa, et al.. (2009). Erythematous plaques on the face: leonine facies. Clinical and Experimental Dermatology. 34(5). 639–640. 2 indexed citations
10.
Koçyiğit, Pelin, et al.. (2007). Post-renal transplantation Leser-Trélat sign associated with carcinoma of the gallbladder: A rare association. Scandinavian Journal of Gastroenterology. 42(6). 779–781. 4 indexed citations
11.
Anadolu, Ranâ, et al.. (2005). Juvenile non‐hyaline fibromatosis: juvenile hyaline fibromatosis without prominent hyaline changes. Journal of Cutaneous Pathology. 32(3). 235–239. 5 indexed citations
12.
Anadolu, Ranâ, Ahu Bırol, Hatice Şanlı, Cengizhan Erdem, & Ümit Türsen. (2004). Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients. International Journal of Dermatology. 44(7). 559–565. 15 indexed citations
13.
Erdem, Cengizhan, et al.. (2003). Juvenile colloid milium associated with conjunctival and gingival involvement. Journal of the American Academy of Dermatology. 49(6). 1185–1188. 7 indexed citations
14.
Anadolu, Ranâ, et al.. (2001). Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. Journal of the American Academy of Dermatology. 45(2). 296–299. 52 indexed citations
15.
Bostancı, Seher, et al.. (2001). Multiple Basal Cell Carcinomas Developed After Radiation Therapy for Tinea Capitis. Dermatologic Surgery. 27(7). 667–669. 1 indexed citations
16.
Erdem, Cengizhan, et al.. (2000). Apopitoz ve Dermatolojideki Önemi. 10(3). 213–221.
17.
Anadolu, Ranâ, et al.. (2000). Subepidermal Büllöz HastalıklardaBazal Membran Bölgesi. 10(4). 275–282.
18.
Atakan, Nilgün & Cengizhan Erdem. (1998). The efficacy, tolerability and safety of a new oral formulation of Sandimmun®‐Sandimmun Neoral® in severe refractory atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 11(3). 240–246. 6 indexed citations
19.
İlhan, Osman, Hamdi Akan, Hakan Koç, et al.. (1997). Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey. PubMed. 39(3). 133–136. 2 indexed citations
20.
Düzgün, Nurşen, et al.. (1997). Lupus vulgaris in a patient with systemic lupus erythematosus and persistent IgG deficiency. Rheumatology International. 16(5). 213–216. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026